ArticlePDF Available

Effect of Biofield Energy Treatment on Streptococcus group B: A Postpartum Pathogen

Authors:
  • Trivedi Global, Inc

Abstract and Figures

Streptococcus agalactiae group B (S. agalactiae gr. B) is widespread in nature mainly causes bacterial septicemia and neonatal meningitis. The current study was attempted to investigate the effect of biofield treatment on S. agalactiae gr. B with respect of antimicrobial sensitivity, biochemical reactions and bio typing. S. agalactiae gr. B strain was used in this experiment bearing the American Type Culture Collection (ATCC 12386) number and stored according to the recommended storage protocol. The revived and lyophilized state of ATCC strains of S. agalactiae gr. B were selected for the study. Gr. I was considered as control. Both revived (Group; Gr. II) and lyophilized (Gr. III) strains of S. agalactiae gr. B were subjected to Mr. Trivedi’s biofield treatment. Gr. II was assessed on day 5 and day 10 while Gr. III on day 10 with respect to the control (Gr. I) using MicroScan Walk-Away® system. Although biofield treatment did not show any change with respect to susceptibility pattern. However the minimum inhibitory concentration of S. agalactiae gr. B showed significant (70.37%) alteration, out of twenty-seven tested antimicrobials, among which in Gr. II i.e. 62.96% on day 5 and 66.67% on day 10 while no alteration was found in lyophilized group (Gr. III) as compared to the control. Moreover, the improvement of MIC value of norfloxacin was observed by two-fold (8 to ≤4 µg/mL) in Gr. II on day 10 after biofield energy treatment as compared to the control. It was observed that overall 48.28% biochemical reactions, out of twenty-nine were altered in Gr. II with respect to the control. Moreover, biotype numbers were changed in Gr. II on day 5 (777777615) and on day 10 (757677405) as compared to the control (237147047). The results suggest that biofield treatment has significant impact on S. agalactiae gr. B in revived treated cells (Gr. II) with respect to MIC values, biochemical reactions pattern and biotype number.
Content may be subject to copyright.
Volume 7(5): 269-273 (2015) - 269
J Microb Biochem Technol
ISSN: 1948-5948 JMBT, an open access journal
Research Article Open Access
Trivedi et al., J Microb Biochem Technol 2015, 7:5
http://dx.doi.org/10.4172/1948-5948.1000223
Research Article
Open Access
Microbial & Biochemical Technology
*Corresponding author: Snehasis Jana, Trivedi Global Inc., 10624 S Eastern
Avenue Suite A-969, Henderson, NV 89052, USA, Tel: +91-755-6660006; E-mail:
publication@trivedisrl.com
Received August 12, 2015; Accepted September 01, 2015; Published September
08, 2015
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015)
Effect of Bioeld Energy Treatment on Streptococcus group B: A Postpartum
Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
Copyright: © 2015 Trivedi MK, et al. This is an open-access article distributed
under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
Abstract
Streptococcus agalactiae group B (S. agalactiae gr. B) is widespread in nature mainly causes bacterial
septicemia and neonatal meningitis. The current study was attempted to investigate the effect of bioeld treatment
on S. agalactiae gr. B with respect of antimicrobial sensitivity, biochemical reactions and bio typing. S. agalactiae
gr. B strain was used in this experiment bearing the American Type Culture Collection (ATCC 12386) number
and stored according to the recommended storage protocol. The revived and lyophilized state of ATCC strains
of S. agalactiae gr. B were selected for the study. Gr. I was considered as control. Both revived (Group; Gr. II)
and lyophilized (Gr. III) strains of S. agalactiae gr. B were subjected to Mr. Trivedi’s bioeld treatment. Gr. II was
assessed on day 5 and day 10 while Gr. III on day 10 with respect to the control (Gr. I) using MicroScan Walk-Away
®
system. Although bioeld treatment did not show any change with respect to susceptibility pattern. However the
minimum inhibitory concentration of S. agalactiae gr. B showed signicant (70.37%) alteration, out of twenty-seven
tested antimicrobials, among which in Gr. II i.e. 62.96% on day 5 and 66.67% on day 10 while no alteration was found
in lyophilized group (Gr. III) as compared to the control. Moreover, the improvement of MIC value of noroxacin was
observed by two-fold (8 to ≤4 µg/mL) in Gr. II on day 10 after bioeld energy treatment as compared to the control.
It was observed that overall 48.28% biochemical reactions, out of twenty-nine were altered in Gr. II with respect to
the control. Moreover, biotype numbers were changed in Gr. II on day 5 (777777615) and on day 10 (757677405)
as compared to the control (237147047). The results suggest that bioeld treatment has signicant impact on S.
agalactiae gr. B in revived treated cells (Gr. II) with respect to MIC values, biochemical reactions pattern and biotype
number.
Effect of Biofield Energy Treatment on
Streptococcus
group B: A
Postpartum Pathogen
Mahendra Kumar Trivedi
1
, Alice Branton
1
, Dahryn Trivedi
1
, Gopal Nayak
1
, Harish Shettigar
1
, Sambhu Charan Mondal
2
and Snehasis Jana
2
*
1
Trivedi Global Inc., 10624 S Eastern Avenue Suite A-969, Henderson, NV 89052, USA
2
Trivedi Science Research Laboratory Pvt. Ltd., Hall-A, Chinar Mega Mall, Chinar Fortune City, Madhya Pradesh, India
Keywords: Streptococcus agalactiae group B; Bioeld treatment;
Minimum inhibitory concentration; Biochemical reaction; Biotype
Abbreviations: CLSI: Clinical and laboratory standards institute;
GBS: Group B Streptococci; CAMP: Christie-Atkins-Munch-Petersen;
CDC: Centers for Disease Control and Prevention; ACOG: American
College of Obstetricians and Gynecologists; AAP: American Academy
of Pediatrics; MIC: Minimum inhibitory concentration; ATCC:
American Type Culture Collection; PBPC 20: Positive Breakpoint
Combo 20
Introduction
Group B Streptococci (GBS), or Streptococcus agalactiae group B,
are Gram-positive, non-spore forming, non-motile, β-hemolytic and
chain-forming cocci bacteria. It is mainly inhabitant in human gut ora
and female urogenital tract [1]. Pregnant women [2] and neonates [3] are
the main victim host of this organism. It can be transferred to neonates
through the birth canal and causes bacterial septicaemia and neonatal
meningitis [4]. Most of GBS, produce Christie-Atkins-Munch-Petersen
(CAMP) factor or protein B an extracellular cytolytic protein and
β-lysin from Staphyllococcus species are jointly lysed the erythrocytes
[5]. It is estimated that in US over 70,000 cases of GBS diseases
were prevented [6]. Several antibiotics such as penicillin, ampicillin,
amoxicillin, cephalosporins (all three generations), macrolides,
clindamycin and vancomycin (as alternative) have been used to treat
against GBS infections. Among above mentioned antibiotics penicillin
is the drug of choice next to cefazolin. However, it also have certain
limitations such as high minimum inhibitory concentration (MIC), a
factor associated with high level of bacteremia and more concentration
of microbes in tissue, especially in cerebrospinal uid [7,8]. erefore,
some alternative treatment strategies are needed to overcome these
lacunas against β-hemolytic strain of gr. B Streptococci. Bioeld
treatment has been known as an alternative approach that may be
useful for S. agalactiae group B infected patients.
Researchers have shown that short-lived electrical events or action
potential exist in the several type of mammalian cells such as neurons,
muscles, and endocrine cells [9]. For instance, when the cells present
in central nervous system of human body communicate with each
another by means of electrical signals that propagate along the nerve
impulses. erefore, it was hypothesized that bioeld exists around
the human body and evidence was found using electromyography,
electrocardiography and electroencephalogram [10]. us, the human
body emits the electromagnetic waves in the form of bio-photons,
which surrounds the body and it is commonly known as bioeld.
erefore, the bioeld consists of electromagnetic eld, being generated
by moving electrically charged particles (ions, cell, molecule etc.) inside
the human body. Rivera-Ruiz reported that electrocardiography has
been extensively used to measure the bioeld of human body [11].
us, human has the ability to harness the energy from environment or
Universe and can transmit into any living or nonliving object(s) around
the Globe. e objects always receive the energy and responding into
useful way that is called bioeld energy and the process is known as
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A
Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
Volume 7(5): 269-273 (2015) - 270
J Microb Biochem Technol
ISSN: 1948-5948 JMBT, an open access journal
bioeld treatment that is also called as Trivedi eect
®
. Mr. Trivedi’s
unique bioeld treatment has been known to transform the structural,
physical, and thermal properties of several metals in material science
[12-14], improved the overall productivity of crops [15,16], altered
characteristics features of microbes [17-19] and improved growth and
anatomical characteristics of various medicinal plants [20,21].
Due to the clinical signicance of this organism and literature
reports on bioeld treatment, the present work was undertaken to
evaluate the impact of bioeld treatment on S. agalactiae group B
in relation to antimicrobials susceptibility and bio typing based on
various biochemical characters.
Materials and Methods
S. agalactiae group B, American Type Culture Collection (ATCC
12386) strains were procured from MicroBioLogics, Inc., USA, in
two sets A and B. Two dierent sealed packs were stored with proper
storage conditions until further use. All the tested antimicrobials and
biochemicals were procured from Sigma-Aldrich, MA, USA. e
antimicrobial susceptibility, biochemical reactions and biotype number
were estimated with the help of MicroScan Walk-Away
®
(Dade Behring
Inc., West Sacramento, CA, USA) using Positive Breakpoint Combo 20
(PBPC 20) panel with respect to the control group.
Experimental design
Two ATCC samples A and B of S. agalactiae gr. B were grouped
(Gr.). ATCC A sample was revived and divided into two parts Gr.I
(control) and Gr.II (revived); likewise, ATCC B was labeled as Gr.III
(lyophilized).
Bioeld treatment strategy
e Gr. I remained as untreated. e treatment Gr. II and III
in sealed pack were handed over to Mr. Trivedi for bioeld energy
treatment under laboratory condition. Mr. Trivedi provided the
treatment through his energy transmission process which includes
bioenergy emission to the treated groups (Gr. II and Gr. III) without
touching the samples. Aer treatment, sample was handed over in the
same condition and stored at standard conditions as per the standard
experimental protocol. An optimum precautionary measure were taken
while evaluating the study parameters throughout the experiments.
e dierences in parameters before and aer the treatment were
noted and compared. Gr.II was assessed at two time point i.e. on day
5 and day 10, while Gr. III was assessed on day 10 for antimicrobial
susceptibility, MIC, biochemical reactions pattern, and biotyping.
Antimicrobial susceptibility test
Investigation of antimicrobial susceptibility of S. agalactiae gr. B
was carried out with the help of automated instrument, MicroScan
Walk-Away
®
system using PBPC 20 panel as per the clinical and
laboratory standards institute (CLSI) guidelines. e test was carried
out on MicroScan, which was miniaturized of the broth dilution
susceptibility test that has been dehydrated. Briey, the standardized
suspension of S. agalactiae gr. B was inoculated, rehydrated, and then
subjected to incubation for 16 hours at 35°C. e detailed experimental
procedures and conditions were followed as per the manufacturer's
instructions. e antimicrobial susceptibility pattern and MIC were
determined by observing the lowest antimicrobial concentration
showing growth inhibition [22].
Biochemical reaction studies
Biochemical reactions of S. agalactiae gr. B were determined using
MicroScan Walk-Away
®
, system with PBPC 20 panel [22]. Biochemicals
used in the study were arabinose, arginine, bacillosamine, bile
esculin, β-lactamases, crystal violet, hemolysin, indoxyl phosphatase,
inulin, acidication lactose, mannitol, mannose, micrococcus screen,
sodium chloride, nitrate, novobiocin, optochin, p-nitro phenyl β-D-
glucuronide, p-nitro phenyl β-D-galactopyranoside, phosphatase,
pyruvate, pyrolidonyl arylamidase, ranose, rambose, sorbitol,
thymidine free growth, acidication trehalose, urea, and Voges-
Proskauer.
Identication of organism by biotype number
e biotype number of S. agalactiae gr. B was determined on
MicroScan Walk-Away
®
processed panel data report with the help of
biochemical reactions data [22].
Results and Discussion
Antimicrobial susceptibility test
e outcomes of MIC values of tested antimicrobials against S.
agalactiae gr. B aer bioeld treatment are summarized in Table 1. e
data were analyzed using automated system and compared with respect
to the control. In this experiment, twelve antibiotics were used to
investigate the susceptibility pattern on GBS viz. ampicillin, cefepime,
cefotaxime, ceriaxone, chloramphenicol, clindamycin, levooxacin,
linezolid, ooxacin, penicillin, tetracycline, and vancomycin. Out
of these, ve antibiotics showed susceptible in the control sample. It
has been evidenced from literatures that penicillin and its derivatives
are the choice of drugs against gr. B streptococcal infection [8,9].
However, bioeld treatment did not show any alteration with respect
to susceptibility pattern in all the treated groups aer bioeld treatment
(data not shown). Besides sensitivity assay, the MIC values of tested
antimicrobials were signicantly (70.37%) altered out of twenty seven
as compared to the control. e MIC value of noroxacin was reduced
by two-fold to ≤ 4 µg/mL aer bioeld treatment in Gr. II on day 10
as compared to the control (8 µg/mL). e MIC values of cefazolin,
cephalothin, and chloramphenicol were changed from ≤ 8 to >16 µg/
mL in Gr. II on day 5 and 10 as compared to the control. e MIC values
of rifampin and synercid were changed from ≤ 1 to >2 µg/mL in Gr. II
on day 5 and 10 as compared to the control. Alteration of MIC values of
cefotaxime and ceriaxone were changed from ≤8 to 32 µg/mL in Gr.
II on day 5 and 10 as compared to the control. Moreover, MIC values
of amoxicillin/k-clavulanate and trimethoprim/sulfamethoxazole
were slightly changed from ≤4/2 to >4/2 µg/mL (on day 5 and 10) and
≤2/38 to >2/38 µg/mL (on day 5) respectively in Gr. II aer bioeld
treatment as compared to the control. Antimicrobial linezolid showed
an alteration of MIC value in Gr. II on day 5 (>4 µg/mL) and on day
10 (4 µg/mL) as compared to the control. Besides this, alteration of
MIC values were observed in case of penicillin (≤ 0.03 to >8 µg/mL),
vancomycin (≤ 0.2 to >16 µg/mL), nitrofurantoin (≤ 32 to >64 µg/mL),
clindamycin (≤ 0.5 to >2 µg/mL), ampicillin (≤ 0.25 to >8 µg/mL) and
ampicillin/sulbactam (≤ 8/4 to >16/8 µg/mL) in Gr. II on day 5 and 10
as compared to the control. e MIC value of tetracycline was changed
from ≤ 4 to 8 µg/mL in Gr. II on day 10 and MIC value of oxacillin
was changed from ≤ 0.25 to >2 µg/mL (on day 5) and 2 µg/mL on day
10 in Gr. II as compared to control. Antimicrobials did not show any
change in MIC value in Gr. III as compared to the control aer bioeld
treatment. Seventeen out of twenty seven (62.96%) antimicrobials
showed alteration of MIC value in Gr. II on day 5 and 66.67% (eighteen
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A
Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
Volume 7(5): 269-273 (2015) - 271
J Microb Biochem Technol
ISSN: 1948-5948 JMBT, an open access journal
such as ranose (RAF) and sorbitol (SOR) showed an alteration of
biochemical reaction i.e. negative (-) to positive (+) in Gr. II on day 5
while remained negative in Gr. II on day 10 and in Gr. III as compared
to the control.
e one of the key characteristic feature for GBS is complete
lysis of red blood cells and metabolization of sugars by fermentation
process. Hence, in control sample the positive reaction of hemolysin
(HEM) indicated β-hemolysis of erythrocytes and positive reaction of
acidifying lactose (LAC) indicated the production of lactic acid as bi-
product. e data was supported with literature [23]. Similarly, based
on existing literature pyrolidonyl arylamidase (PYR) has negative
reaction in group B streptococcal species while positive reaction in
group A streptococcal. Control data of PYR was well supported with
literature data [24]. However, aer bioeld treatment the negative
reaction was altered in Gr. II, assessed on day 5 as well as day 10 due to
change of enzymatic reaction.
Overall, 48.28% biochemical reactions were altered in tested
twenty-nine biochemicals with respect to the control aer bioeld
treatment. In both time points of Gr. II (day 5 and 10) 41.38% (twelve
out of twenty-nine) biochemical reactions were altered as compared
to the control. About 51.72% out of twenty-nine biochemicals, such as
arabinose (ARA), bacillosamine (BAC), β-lactamase (BL), hemolysin
(HEM), indoxyl phosphatase (IDX), inulin (INU), acidication lactose
(LAC), mannose (MNS), micrococcus screen (MS), optochin (OPT),
glycosidase (PGT), phosphatase (PHO), thymidine free growth (TFG),
acidication trehalose (TRE), and Voges-Proskauer (VP) did not
out of twenty seven) on day 10 as compared to the control aer bioeld
treatment. Eight, out of twenty seven tested antimicrobials (29.63%)
viz. cefepime, ciprooxacin, gatioxacin, imipenem, levooxacin,
moxioxacin, ooxacin and piperacillin/tazobactam did not show any
alteration of MIC values in all the treated cells of GBS as compared to
the control (Table 1).
Biochemical reactions studies
Study of biochemical reactions can be utilized to identify
the enzymatic and metabolic characteristic features of microbes.
Microorganisms can be categorically dierentiated based on their
utilization of specic biochemicals as nutrients during the process of
metabolism or enzymatic reactions. e specic biochemical showed
some changes against S. agalactiae gr. B aer bioeld treatment that
are shown in Table 2. Biochemicals such as bile esculin (BE), crystal
violet (CV), mannitol (MAN), sodium chloride (NaCl), nitrate (NIT),
novobiocin (NOV), pyrolidonyl arylamidase (PYR) and urea (URE)
were changed from negative (-) to positive (+) reactions in revived
treated group (Gr. II) on day 5 and 10, but remained same i.e. negative
(-) reaction in lyophilized treated cells (Gr. III) with respective to
control. Arginine (ARG) and glycosidase (PGR) were converted
from positive (+) to negative (-) reactions in Gr. II on day 10, while
remained unchanged i.e. positive (+) on day 5 in Gr. II and in Gr. III as
compared to the control in bioeld treated S. agalactiae gr. B. Similarly,
pyruvate (PRV), and rambose (RBS) were converted from positive (+)
to negative (-) reactions on both days in Gr. II, while did not show any
change in Gr. III as compared with the control. Moreover, biochemicals
Table 1: Effect of bioeld treatment on Streptococcus agalactiae group B to minimum inhibitory concentration (MIC) of tested antimicrobials.
S. No. Antimicrobial Type of Response
Gr. I Gr. II Gr. III
Day 5 Day 10
1. Amoxicillin/k-clavulanate ≤4/2 >4/2 >4/2 ≤4/2
2. Ampicillin/sulbactam ≤8/4 >16/8 >16/8 ≤8/4
3. Ampicillin ≤0.25 >8 >8 ≤0.25
4. Cefazolin ≤8 >16 >16 ≤8
5. Cefepime ≤8 ≤8 ≤8 ≤8
6. Cefotaxime ≤8 32 32 ≤8
7. Ceftriaxone ≤8 32 32 ≤8
8. Cephalothin ≤8 >16 >16 ≤8
9. Chloramphenicol ≤8 >16 >16 ≤8
10. Ciprooxacin ≤1 ≤1 ≤1 ≤1
11. Clindamycin ≤0.5 >2 >2 ≤0.5
12. Gatioxacin ≤2 ≤2 ≤2 ≤2
13. Imipenem ≤4 ≤4 ≤4 ≤4
14. Levooxacin ≤2 ≤2 ≤2 ≤2
15. Linezolid ≤2 >4 4 ≤2
16. Moxioxacin ≤2 ≤2 ≤2 ≤2
17. Nitrofurantoin ≤32 >64 >64 ≤32
18. Noroxacin 8 8 ≤4 8
19. Ooxacin ≤2 ≤2 ≤2 ≤2
20. Oxacillin ≤0.25 >2 2 ≤0.25
21. Penicillin ≤0.03 >8 >8 ≤0.03
22. Piperacillin/tazobactam ≤4 ≤4 ≤4 ≤4
23. Rifampin ≤1 >2 >2 ≤1
24. Synercid ≤1 >2 >2 ≤1
25. Tetracycline ≤4 ≤4 8 ≤4
26. Trimethoprim/sulfamethoxazole ≤2/38 >2/38 ≤2/38 ≤2/38
27. Vancomycin ≤2 >16 >16 ≤2
MIC values are presented in µg/mL; Gr.: Group
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A
Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
Volume 7(5): 269-273 (2015) - 272
J Microb Biochem Technol
ISSN: 1948-5948 JMBT, an open access journal
show any change in all the treated groups aer bioeld treatment as
compared to the control.
Identication of organism by biotype number
e species (S. agalactiae gr. B) was identied based on variety of
conventional biochemical characters and biotyping. Biotype number of
particular organism was evaluated aer interpreting the results of the
biochemical reactions. e biotype number then led to the particular
organism identication. In this experiment, biotyping was performed
using automated systems. Results showed changes of biotype numbers
in the bioeld treated Gr. II (on day 5 and 10) and Gr. III (on day
10) without alteration of organism. Based on the biochemical data,
biotype number was changed in treated Gr. II on day 5 (777777615,
S. agalactiae group B) and on day 10 (757677405, S. agalactiae group
B) with respect to the control (237147047) i.e. S. agalactiae group B
(Table 3). Biotyping, covers the overall cellular pattern of enzymatic
activities of any organism. GBS can be characterized based on analysis
of biochemical properties with CAMP, Na-hippurate positive and
esculin negative as key characters [25]. In this experiment, bile esculin
also showed negative (-) reaction in control sample, that directly
correlated with literature. is negative reaction of esculin was altered
aer bioeld treatment in revived treated cells of GBS. It was indicated
that bioeld treatment has the ability to alter the biochemical pattern
which may be due to change the enzymatic reaction. So, it is assumed
that these changes of biotype number without alteration in organism
may be due to change of metabolic and/or enzymatic reactions of GBS.
Bioeld treatment may responsible for alteration in microorganism
at genetic and/or enzymatic level, which probably act on receptor protein.
While altering receptor protein, ligand-receptor/protein interactions
may alter that could lead to dierent phenotypic characteristics [26].
Bioeld treatment might induce a signicant changes in revived
strain of GBS and altered the MIC values, biochemical reactions, and
ultimately change the biotype number of microorganism.
Conclusion
Altogether, the bioeld treatment has signicantly altered 70.37%,
(out of twenty-seven) the MIC values of tested antimicrobials against
the strain of S. agalactiae gr. B. Noroxacin was improved the MIC value
by two-fold (8 to ≤4 µg/mL) in Gr. II on day 10 aer bioeld energy
treatment as compared to the control. Additionally, it also signicantly
(48.28%) altered the biochemical reactions pattern of bioeld energy
treated strain of S. agalactiae gr. B. On the basis of utilization of group
B streptococcal specic biochemicals, change in metabolic reactions led
to variation of biotype number in all the treated groups without change
of organism aer bioeld treatment with respect to the control. Based
on above ndings, it is assumed that Mr. Trivedi’s bioeld treatment is
Table 2: Effect of bioeld treatment on Streptococcus agalactiae group B to the biochemical reaction pattern.
S. No. Code Biochemical Gr. I Type of Response
Gr. II Gr. III
Day 5 Day 10
1. ARA Arabinose - - - -
2. ARG Arginine + + - +
3. BAC Bacillosamine + + + +
4. BE Bile esculin - + + -
5. BL Beta lactamases NR NR NR NR
6. CV Crystal violet - + + -
7. HEM Hemolysin + + + +
8. IDX Indoxyl phosphatase + + + +
9. INU Inulin - - - -
10. LAC Acidication lactose + + + +
11. MAN Mannitol - + + -
12. MNS Mannose + + + +
13. MS Micrococcus screen + + + +
14. NaCl Sodium chloride - + + -
15. NIT Nitrate - + + -
16. NOV Novobiocin - + + -
17. OPT Optochin + + + +
18. PGR Glycosidase
*
+ + - +
19. PGT Glycosidases
#
+ + + +
20. PHO Phosphatase + + + +
21. PRV Pyruvate + - - +
22. PYR Pyrolidonyl arylamidase - + + -
23. RAF Rafnose - + - -
24. RBS Rambose + - - +
25. SOR Sorbitol - + - -
26. TFG Thymidine free growth + + + +
27. TRE Acidication trehalose + + + +
28. URE Urea - + + -
29. VP Voges-Proskauer + + + +
‘-’ (negative); ‘+’ (positive); Gr.: Group; NR: Not reported; *PGR: p-nitro phenyl β-D- glucuronide; #PGT: p-nitro phenyl β-D-galactopyranoside.
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015) Effect of Bioeld Energy Treatment on Streptococcus group B: A
Postpartum Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-5948.1000223
Volume 7(5): 269-273 (2015) - 273
J Microb Biochem Technol
ISSN: 1948-5948 JMBT, an open access journal
an alternative approach to alter the antibiogram prole of S. agalactiae
gr. B.
Acknowledgement
Authors gratefully acknowledged to Trivedi science, Trivedi testimonials and
Trivedi master wellness and the whole team of PD Hinduja National Hospital and
MRC, Mumbai, Microbiology Lab for their support.
References
1. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, et al. (2000) Group
B Streptococcal colonization and serotype-specic immunity in pregnant
women at delivery. Obstet Gynecol 96: 498-503.
2. Cowgill K, Taylor TH Jr, Schuchat A, Schrag S (2003) Report from the CDC.
Awareness of perinatal group B streptococcal infection among women of
childbearing age in the United States, 1999 and 2002. J Womens Health
(Larchmt) 12: 527-532.
3. Mullaney DM (2001) Group B streptococcal infections in newborns. J Obstet
Gynecol Neonatal Nurs 30: 649-658.
4. van der Poll T, Opal SM (2008) Host-pathogen interactions in sepsis. Lancet
Infect Dis 8: 32-43.
5. Ratner HB, Weeks LS, Stratton CW (1986) Evaluation of spot CAMP test for
identication of group B streptococci. J Clin Microbiol 24: 296-297.
6. Schuchat A, Wenger JD (1994) Epidemiology of group B streptococcal disease.
Risk factors, prevention strategies, and vaccine development. Epidemiol Rev
16: 374-402.
7. Jacobs MR, Kelly F, Speck WT (1982) Susceptibility of group B streptococci
to 16 beta-lactam antibiotics, including new penicillin and cephalosporin
derivatives. Antimicrob Agents Chemother 22: 897-900.
8. McCracken GH Jr, Ginsberg C, Chrane DF, Thomas ML, Horton LJ (1973)
Clinical pharmacology of penicillin in newborn infants. J Pediatr 82: 692-698.
9. Myers R (2003) The basics of chemistry. Greenwood Press, Westport,
Connecticut.
10. Movaffaghi Z, Farsi M (2009) Bioeld therapies: biophysical basis and biological
regulations? Complement Ther Clin Pract 15: 35-37.
11. Rivera-Ruiz M, Cajavilca C, Varon J (2008) Einthoven's string galvanometer:
the rst electrocardiograph. Tex Heart Inst J 35: 174-178.
12. Trivedi MK, Tallapragada RM (2008) A transcendental to changing metal
powder characteristics. Met Powder Rep 63: 22-28, 31.
13. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Studies of
the atomic and crystalline characteristics of ceramic oxide nano powders after
Bioeld treatment. Ind Eng Manage 4: 161.
14. Dabhade VV, Tallapragada RR, Trivedi MK (2009) Effect of external energy
on atomic, crystalline and powder characteristics of antimony and bismuth
powders. Bull Mater Sci 32: 471-479.
15. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of bioeld
treatment on ginseng and organic blueberry yield. Agrivita J Agric Sci 35: 22-29.
16. Lenssen AW (2013) Bioeld and fungicide seed treatment inuences on
soybean productivity, seed quality and weed community. Agricultural Journal
83: 138-143.
17. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial
sensitivity pattern of Pseudomonas uorescens after bioeld treatment. J Infect
Dis Ther 3: 222.
18. Trivedi MK, Patil S, Shettigar H, Bairwa K, Jana S (2015) Phenotypic and
biotypic characterization of Klebsiella oxytoca: An impact of bioeld treatment.
J Microb Biochem Technol 7: 203-206.
19. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) An effect of bioeld
treatment on multidrug-resistant Burkholderia cepacia: A multihost pathogen.
J Trop Dis 3: 167.
20. Patil SA, Nayak GB, Barve SS, Tembe RP, Khan RR (2012) Impact of bioeld
treatment on growth and anatomical characteristics of Pogostemon cablin
(Benth.). Biotechnology 11: 154-162.
21. Nayak G, Altekar N (2015) Effect of bioeld treatment on plant growth and
adaptation. J Environ Health Sci 1: 1-9.
22. Fader RC, Weaver E, Fossett R, Toyras M, Vanderlaan J, et al. (2013)
Multilaboratory study of the biomic automated well-reading instrument versus
MicroScan WalkAway for reading MicroScan antimicrobial susceptibility and
identication panels. J Clin Microbiol 51: 1548-1554.
23. Kaufhold A, Ferrieri P (1993) The microbiologic aspects, including diagnosis, of
beta-hemolytic streptococcal and enterococcal infections. Infect Dis Clin North
Am 7: 235-256.
24. Facklam RR, Thacker LG, Fox B, Eriquez L (1982) Presumptive identication of
streptococci with a new test system. J Clin Microbiol 15: 987-990.
25. Ekin IH, Gurturk K, Yaman G, Yesilova A (2010) Biotyping of nontypeable
Group B Streptococci. Van Vet J 21: 117-122.
26. Lindstrom E, Mild KH, Lundgren E (1998) Analysis of the T cell activation
signaling pathway during ELF magnetic eld exposure, p56
lck
and [Ca
2+
]
i
-measurements. Bioeletrochem Bioenerg 46: 129-137.
Table 3: Effect of bioeld treatment on biotype number of Streptococcus agalactiae group B.
Feature Gr. I Gr. II Gr. III
Day 5 Day 10 Day 10
Biotype 237147047 777777615 757677405 237147047
Organism Identication Streptococcus agalactiae group B Streptococcus agalactiae group B
(Very rare biotype)
Streptococcus agalactiae group B
(Very rare biotype)
Streptococcus agalactiae group B
Gr.: Group
OMICS International: Publication Benefits & Features
Unique features:
• Increasedglobalvisibilityofarticlesthroughworldwidedistributionandindexing
• Showcasingrecentresearchoutputinatimelyandupdatedmanner
• Specialissuesonthecurrenttrendsofscienticresearch
Special features:
• 700OpenAccessJournals
• 50,000editorialteam
• Rapidreviewprocess
• Qualityandquickeditorial,reviewandpublicationprocessing
• IndexingatPubMed(partial),Scopus,EBSCO,IndexCopernicusandGoogleScholaretc
• SharingOption:SocialNetworkingEnabled
• Authors,ReviewersandEditorsrewardedwithonlineScienticCredits
• Betterdiscountforyoursubsequentarticles
Submityourmanuscriptat:http://www.editorialmanager.com/jmbt
Citation: Trivedi MK, Branton A, Trivedi D, Nayak G, Shettigar H, et al. (2015)
Effect of Bioeld Energy Treatment on Streptococcus group B: A Postpartum
Pathogen. J Microb Biochem Technol 7: 269-273. doi:10.4172/1948-
5948.1000223
... The Trivedi Effect ® -Biofield Energy Healing has been known to improve the potential beneficial effects in a broad spectrum field around the Globe. It improved the overall productivity of crops in agriculture and livestoc [7][8][9][10] , positive impact on cancer [11,12] , and altered characteristics features of microbes in the field of microbiology [13][14][15][16] . It also altered the structural, physical, and thermal properties of several metals and ceramics [17][18][19] , causes chromosomal changes in microbes [20,21] , and improved various nutraceutical compounds in the areas of nutraceuticals [22,23] and biotechnology [24][25][26] . ...
Article
Full-text available
The objective of the present study was to evaluate the immunomodulatory effect of Biofield Energy Treatment (The Trivedi Effect®) on Dulbecco’s Modified Eagle’s Medium (DMEM) and fetal bovine serum (FBS) in murine macrophage cells (RAW 264.7). The study parameters were evaluated using cell viability by MTT assay and estimation of proinflammatory cytokine like tumor necrosis factor - alpha (TNF-α) on immunomodulation using enzyme linked immune sorbent assay (ELISA). The cell viability using MTT assay data showed that more than 80% cell viability was observed in all the tested groups compared to the baseline control group (G1). The characteristics of cell morphology in the Biofield Energy Treated DMEM without FBS (G6) group showed some changes in the cell morphology as evidenced a transition from spherical to elongate and also showed maturation compared to the G1 group. The level of TNF-α expression was significantly reduced by 23.15% in the G3 group compared to the G1 group. Moreover, the secretion of TNF-α was altered by 38.06%, 35.77%, and 282.49% in the G4, G5, and G6 groups, respectively compared to the G1 group. The overall results demonstrated that the Trivedi Effect® - Consciousness Energy Healing Treatment has an impact on DMEM and FBS by alteration of cell morphology and reducing the level of TNF-α expression in immune cell (RAW 264.7). Therefore, the Trivedi Effect® treated DMEM and FBS might be useful as an immunomodulator for various immune-related disorders like Graves’ disease, rheumatoid arthritis, multiple sclerosis, etc.
... Mr. Mahendra Kumar Trivedi's Biofield Energy Treatment (The Trivedi Effect ® ) has been scientifically studied and reported in various fields. The significance of The Trivedi Effect ® has been reported in cancer research [13,14] , microbiology with changed antimicrobial sensitivity pattern [15][16][17][18] , improved the overall productivity of crops in agriculture and livestock [19][20][21][22] , significant results in different nutraceutical and pharmaceutical compounds [23][24][25][26][27][28] , and altered structural, physical, and thermal properties of several metals and ceramics [29][30][31] . Different number of wound healing evaluation methods are available, but in vitro assays are always preferred not only due to ethical and financial constraint, but also they can be carried out in small-scale bioassays, analyze the cell migration and cell interactions. ...
Article
Full-text available
The wound healing activity using scratch assay is considered as a convenient in vitro tool for the assessment of wound healing. The present study deals with the optimization of Biofield Energy Treatment (Consciousness Energy Healing Treatment-The Trivedi Effect®) in the HFF-1 cell line (Human Foreskin Fibroblast) and DMEM (Dulbecco’s Modified Eagle Medium) using scratch assay against positive control, recombinant Human Epidermal Growth Factor (Hu EGF, 30 ng/mL). This method was used for the determination of cell proliferation and migration of fibroblast quantitatively in the scratched wounded area. The scratched area was monitored after 24 hours of wound closure in the Biofield Energy Treated HFF-1 cells and the Biofield Energy Treated DMEM groups, and the representative photomicrographs were taken in each wells using Wim Scratch Image analysis software. The results showed that the Biofield Energy Treated DMEM was significantly higher percentage of fibroblast migration i.e. 51.8%, while the migration was altered in the Biofield Energy Treated HFF-1 cell line compared to the baseline control group. In addition to, the percentage of scratch area was significantly decreased by 2.7% in the Biofield Energy Treated DMEM group, while it was increased by 12% in the Biofield Treated cells group compared to the baseline control group. Overall, the experimental results concluded that The Trivedi Effect® has the significant capacity and wide implications in wound healing activity via cell culture media, DMEM as compared with the HFF-1 cell line directly. Biofield Energy Healing would be a complementary and alternative medicine that can be used against burn injury cases, acute wound, skin regeneration, eczema, diaper rash, chickenpox, measles, warts, acne, hives, wrinkles, ringworm, Rosacea, psoriasis, seborrheic dermatitis, skin cancer, etc.
... The Trivedi Effect ® -Biofield Energy Healing has been known to improve the potential beneficial effects in a broad spectrum field around the Globe. It improved the overall productivity of crops in agriculture and livestock [9][10][11][12], positive impact on cancer [13,14], and altered characteristics features of microbes in the field of microbiology [15][16][17][18]. It also alters the structural, physical, and thermal properties of several metals and ceramics [19][20][21], causes genetic alteration in microbes [22,23], and improves various nutraceutical compounds in the areas of nutraceuticals [24,25] and biotechnology [26][27][28]. ...
Article
Full-text available
The bone health is an important part of healthy-life and longevity in general. The present study was investigated to see the effect of the Biofield Energy Healing (The Trivedi Effect®) on the human bone osteosarcoma cells - MG-63 (ATCC® CRL-1427™) for the assessment of bone cell proliferation and differentiation in vitro. The study parameters were assessed using cell viability by MTT, collagen synthesis, and alkaline phosphatase (ALP) on bone health using ELISA-based assay. The cell viability assay data showed significant response in all the tested groups; while in the Biofield Energy Treated group supplemented with 10% charcoal-dextran treated fetal bovine serum (CD-FBS) (G3) showed better response (increased 63%) in terms of cells proliferation compared to the untreated cell group (G1). The level of ALP was increased by 32% in the G3 group compared to the untreated cells group (G1). Additionally, the level of collagen synthesis was increased by 27% in the G3 group compared to the G1 group. The overall results demonstrated that the Biofield Energy Treatment has the potential for bone mineralization and bone growth as evident via increased levels of collagen and ALP. Therefore, the Biofield Energy Healing (The Trivedi Effect®) Treatment might be useful as a bone health promoter for various bone-related disorders like low bone density, osteogenesis imperfecta, and osteoporosis.
... The Trivedi Effect ® -Biofield Energy Healing has been known to improve the potential beneficial effects in a broad spectrum field around the globe. It improved the productivity of crops in agriculture and livestock [12][13][14][15], positive impact on cancer [16,17], and altered characteristics features of microbes in the field of microbiology [19][20][21]. It also alters the structural, physical, and thermal properties of several metals and ceramics [22][23][24], causes genetic alteration in various microorganisms [25,26], and improves various nutraceutical compounds in the areas of nutraceuticals [27,28] and biotechnology [29][30][31]. ...
Article
Full-text available
The bone health is an important part of healthy-life and longevity in current situation due to huge toxins and contaminants in the environment and food chain. Considering the importance of bone health in the modern era, the present study was undertaken to investigate the effect of the Consciousness Energy Healing (The Trivedi Effect®) Treatment on Dulbecco's Modified Eagle Medium (DMEM) in which the human bone osteosarcoma cells - MG-63 (ATCC® CRL-1427™) was grown for the assessment of bone cell proliferation and differentiation in vitro. The study parameters were assessed using cell viability by MTT assay, alkaline phosphatase (ALP), and collagen synthesis on bone health using ELISA-based assay. The cell viability was significantly increased by 24% in the Biofield Energy Treated group supplemented with 10% charcoal-dextran with fetal bovine serum (CD-FBS) (G3) compared to the untreated cells group (G1). The level of ALP was significantly increased by 72% in the G3 group compared to the G1 group. Additionally, the level of collagen synthesis was significantly (p≤0.001) increased by 19% in the G3 group compared to the G1 group. The overall results demonstrated that the Biofield Energy Treated DMEM has the potential for bone mineralization and bone cells growth as evident via increased levels of collagen and ALP. Therefore, the Biofield Energy Healing (The Trivedi Effect®) Treatment could be useful as a bone health promoter for various bone-related disorders like low bone density, osteogenesis imperfecta, and osteoporosis, etc.
... Consciousness Energy Healing Treatment (The Trivedi Effect ® ) has been reported with noteworthy results in nonliving materials and living organisms. The momentous results of The Trivedi Effect ® have been published in the field of microbiology [12][13][14], agriculture science [15][16][17], livestock [18], nutraceuticals [19,20], and materials science [21][22][23]. On this basis, the present study was designed to evaluate the effect of Biofield Energy Treatment (The Trivedi Effect ® ) on HFF-1 cell line and DMEM for evaluation of cellular proliferation rate using MTT assay and cell growth assay using phase contrast microscopy. ...
Article
Full-text available
Cell growth and proliferation plays an important role in wound healing, which is a complex and dynamic process. Wound management and recovery is currently done using various antiseptics and antibiotics in order to prevent or treat infection. The objective of the present study was to assess the effect of Biofield Energy (Consciousness Energy Healing Treatment - The Trivedi Effect®) Treated cell growth medium on the proliferation of human dermal fibroblast cells (HFF-1) for the assessment of skin health promotion potential. An aliquot of HFF-1 cells and DMEM were divided into two parts, one was treated with the Biofield Energy Treatment and denoted as the treated test samples, while other part was coded as the untreated test samples. MTT assay was used to study the cellular proliferation, while cell growth rate was estimated under phase contrast microscope by monitoring the cell growth at 24, 48, and 72 hours interval and photomicrographs were captured. The results of HFF-1 cellular proliferation rate showed a significant (p≤0.001) increased by 80% in the Biofield Energy Treated DMEM, while positive controls, ascorbic acid (10 µM) and FBS (15% fetal bovine serum) showed increased cell proliferation by 21% and 44%, respectively. In addition, cell growth rate was evaluated at 24, 48, and 72 hours and the results were observed with a significant growth in the Biofield Energy Treated DMEM group compared with the Biofield Energy Treated HFF-1 cells. Thus, on the basis of the experimental results, it can be concluded that The Trivedi Effect®-Consciousness Energy Healing Treatment has the significant capacity to improve the cellular proliferation and cell growth rate of human skin cells in the Biofield Energy Treated media (DMEM) for improving the overall skin health. It can be used as a complementary and alternative approach with respect to the various skin-related disorders, anti-aging, wound healing, and many more.
... Mr. Mahendra Kumar Trivedi's Biofield Energy Treatment (The Trivedi Effect ® ) has been scientifically studied and reported in various fields. The significance of The Trivedi Effect ® has been reported in cancer research [13,14] , microbiology with changed antimicrobial sensitivity pattern [15][16][17][18] , improved the overall productivity of crops in agriculture and livestock [19][20][21][22] , significant results in different nutraceutical and pharmaceutical compounds [23][24][25][26][27][28] , and altered structural, physical, and thermal properties of several metals and ceramics [29][30][31] . Different number of wound healing evaluation methods are available, but in vitro assays are always preferred not only due to ethical and financial constraint, but also they can be carried out in small-scale bioassays, analyze the cell migration and cell interactions. ...
Article
The wound healing activity using scratch assay is considered as a convenient in vitro tool for the assessment of wound healing. The present study deals with the optimization of Biofield Energy Treatment (Consciousness Energy Healing Treatment-The Trivedi Effect®) in the HFF-1 cell line (Human Foreskin Fibroblast) and DMEM (Dulbecco's Modified Eagle Medium) using scratch assay against positive control, recombinant Human Epidermal Growth Factor (Hu EGF, 30 ng/mL). This methodwas used for the determination of cell proliferation and migration of fibroblast quantitatively in the scratched wounded area. The scratched area was monitored after 24 hours of wound closure in the Biofield Energy Treated HFF-1 cells and the Biofield Energy Treated DMEM groups, and the representative photomicrographs were taken in each wells using WimScratch Image analysis software. The results showed that the Biofield Energy Treated DMEMwassignificantly higher percentage of fibroblast migration i.e. 51.8%, while the migration was altered in the Biofield Energy Treated HFF-1 cell line compared to the baseline control group. In addition to, the percentage of scratch area was significantly decreased by 2.7% in the Biofield Energy Treated DMEM group, while it was increased by 12% in the Biofield Treated cells group compared to the baseline control group. Overall, the experimental results concluded that The Trivedi Effect® has the significant capacity and wide implications in wound healing activityvia cell culture media, DMEM as compared with the HFF-1 cell line directly. Biofield Energy Healing would be a complementary and alternative medicine that can be used against burn injury cases, acute wound, skin regeneration, eczema, diaper rash, chickenpox, measles, warts, acne, hives, wrinkles, ringworm, Rosacea, psoriasis, seborrheic dermatitis, skin cancer, etc.
... Biofield Energy Healing Treatment has gained rapid rapport as a holistic alternative and complementary medicine therapy that has significant impact on living organisms and nonliving materials without any adverse effects and in a manner that is more cost-effective than more conventional methods. Biofield Energy Treatment (The Trivedi Effect ® ) results has been published in numerous peer-reviewed science journals with significant outcomes in many scientific fields such as cancer research [15], microbiology [16][17][18], biotechnology [19], genetics [20,21], pharmaceutics [22,23], nutraceuticals [24], organic compounds [25,26], agricultural science [27][28][29], and altered the structure of the atom in many metals, ceramics, polymers and chemicals in materials science [30][31][32]. In this study, the authors sought to explore the impact of the Biofield Energy Treatment (The Trivedi Effect ® ) on the given herbomineral formulation and Biofield Energy Treatment per se to the animals, which might improve the immunomodulatory function with respect to the antibody titre, delayed type hypersensitivity reaction, body weight change, feed consumption, hematological parameters, and serum biochemistry using standard assays. ...
Article
Full-text available
A new proprietary herbomineral formulation was formulated, consisting of an essential ingredients viz. an herbal root extract ashwagandha and minerals (zinc, magnesium, and selenium). The aim of this study was to evaluate the immunomodulatory potential of Energy of Consciousness Healing (The Trivedi Effect®) Treatment on the herbomineral formulation in male Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals was also received Biofield Energy Treatment per se (day -15) by Biofield Energy Healers under similar conditions. The immunological parameters viz. humoral immune analysis, paw volume, hematological study, biochemistry, body weight, feed and water intake, and histopathology analysis were performed in this experiment. The humoral immune response data showed the secondary antibody titre was significantly increased by 112.50% and 87.50% in the Biofield Energy Treated test formulation group (G4) and untreated test formulation group (G5) compared to the disease control group (G2). The results of delayed type hypersensitivity showed significant increased the paw volume by 111.76%, 51.45%, 100%, and 64.80% in the G4, G5, Biofield Energy Treatment group per se at day -15 (G6) and Biofield Energy Treated test formulation at day -15 (G7) groups, respectively compared to the G2 group. The platelet count was significantly increased by 37.72%, 8.69%, 16.30% and 33.11% in the G4, G5, G6, and G7 groups, respectively compared to the G2 group. The level of blood urea nitrogen was significantly decreased by 14.01% in the G4 group compared to the disease control. Moreover, the concentration of uric acid was significantly reduced by 28.97% in the G7 group compared to the G2 group. Animal weight parameters suggested that there were no treatment-related changes in any group. Organ to body weight ratio, feed and water intake data described that the Biofield Energy Treated test formulation was found to be safe without any side-effect during the course of the experiment. Overall, results suggested that the Biofield Energy Treated herbomineral formulation and Biofield Energy Treatment per se can be used for autoimmune and inflammatory diseases, stress management and prevention, and anti-aging by improving overall health.
... Biofield Energy Healing Treatment has gained rapid rapport as a holistic alternative and complementary medicine therapy that has significant impact on living organisms and nonliving materials without any adverse effects and in a manner that is more cost-effective than more conventional methods. Biofield Energy Treatment (The Trivedi Effect ® ) results has been published in numerous peer-reviewed science journals with significant outcomes in many scientific fields such as cancer research [18], microbiology [19][20][21], biotechnology [22], genetics [23,24], pharmaceutics [25,26], nutraceuticals [27], organic compounds [28,29], agricultural science [30][31][32], and changing the structure of the atom in relation to various metals, ceramics, polymers and chemicals in materials science [33][34][35]. ...
Article
Full-text available
A new proprietary herbomineral formulation was formulated, consisting of essential ingredients viz. herbal root extract ashwagandha and minerals (zinc, magnesium, and selenium). The aim of the study was to evaluate the immunomodulatory potential of Consciousness Energy Healing Treatment on the herbomineral formulation in male Sprague Dawley rats. The test formulation was divided into two parts. One part was denoted as the control without any Biofield Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals also received Biofield Energy Treatment per se (day -15) by Biofield Energy Healers under similar conditions. The test formulation was evaluated for immunological parameters viz. humoral immune analysis, paw volume, hematological study, biochemistry, body weight, feed and water intake, and histopathology analysis were performed. The humoral immune response showed a significant increased primary and secondary antibody titre values by 26% and 150.4%, respectively in Biofield Energy Treatment per se group (G6, day -15), while primary and secondary antibody titre values were increased by 100.0% and 110.4%, respectively in the Biofield Energy Treated test formulation (G7, day -15) group compared with the disease control group (G2). The results of delayed type hypersensitivity showed a significant increase in the paw volume by 94.44% in the Biofield Energy Treated test formulation (G4) group with respect to the G2 group. However, a significant increase in paw volume by 61.11% and 44.44% was found in G6 and G7 group, respectively with respect to the G2 group. Hematological parameters showed a significant (p<0.001) increased platelet count by 85.6% in the G4 group, while 39.15% and 35.22% increase in the G6 and G7 groups, respectively compared with the G2 group. In biochemical analysis, a significant increase in calcium and phosphorus level were found in the G4 group compared with the G2 group. Animal weight parameters suggests that there were no treatment-related changes in any group, organ to body weight ratio, feed and water intake. The data described that the Biofield Energy Treated test formulation was found to be safe without any side effect during the course of the experiment. These data suggests that the Biofield Energy Treated test formulation and Biofield Energy Treatment per se can be used for autoimmune and inflammatory diseases, enhancing stress management and prevention, and anti-aging by improving overall health.
... Biofield Energy Treatment (The Trivedi Effect ® ) has been reported with noteworthy results in nonliving materials and living organisms. The Trivedi Effect ® has been reported with momentous results in the field of microbiology [20][21][22], agriculture science [23][24][25], livestock [26], and materials science [27][28][29]. On this basis, a novel Biofield Energy Healing based herbomineral formulation has been designed for skin care treatment. ...
Article
Full-text available
The application of the herbomineral formulations in general skin health are increasing day-by-day due to the excellent outcomes without any adverse effects. This study was designed to evaluate the influence of The Trivedi Effect®-Consciousness Energy Healing Treatment on an herbomineral formulation and cell medium against various skin health parameters. The test formulation consists of minerals (zinc chloride, sodium selenate, and sodium molybdate) and L-ascorbic acid along with herbal extracts, Centella asiatica, and tetrahydrocurcumin (THC). The test formulation and DMEM media were divided into two equal parts, one was treated with a Biofield Treatment (BT) by Dezi Ann Koster and denoted as treated, while the other part was coded as the untreated (UT) groups. MTT assay results showed that test formulation was safe and nontoxic with more than 89% cell viability in the tested cell lines. BrdU assay showed an improved cell proliferation by 2.82% in the UT-DMEM + BT-Test formulation group compared with the untreated group. The level of collagen was significantly increased by 32.42%, 33.64%, and 29.13% at 2.5, 1.25 and 0.625 µg/mL, respectively in the UT-DMEM + BT-Test formulation, while34.17%, 26.73%, and 17.56% increased at 2.5, 1.25 and 0.625 µg/mL, respectively in BT-DMEM + BT-Test formulation group compared with the untreated group. Elastin level was increased by 408.6% at concentration of 0.625 µg/mL in UT-DMEM + BT-Test formulation group compared with untreated group. However, hyaluronic acid (HA) level was increased by 31.88%, 15.52%, and 58.29% at 2.5, 1.25, and 0.625 µg/mL, respectively in the BT-DMEM + BT-Test formulation group compared with untreated group. Besides, melanin synthesis was significantly inhibited by 16.09% and 18.93% in the UT-DMEM + BT-Test formulation and BT-DMEM + UT-Test formulation groups, respectively at 0.125 µg/mL compared with the untreated group. Anti-wrinkling activity in HFF-1 cells showed an improved cell viability by 5.49% and 11.26% at 1.25 and 0.625 µg/mL, respectively in BT-DMEM + BT-Test formulation group compared with the untreated group. Wound healing scratch assay results showed a significant healing rate by 5% and 10% in HFF-1 and HaCaT cells lines, respectively with high cellular migration of fibroblast and keratinocytes. Overall, it can be concluded that the Biofield Energy Healing (The Trivedi Effect®) based test formulation and cell medium could be helpful against various skin disorders and can be used in psoriasis, seborrheic dermatitis, skin cancer, rashes from bacterial or fungal infections as anti-wrinkling, skin-whitening, anti-ageing, and rejuvenating agent.
Article
Full-text available
Skin reflects the correlation between the overall inner-health and aging status, which is the complex biological process influenced by the various factors. The present work evaluated the impact of Biofield Energy (The Trivedi Effect®-Consciousness Energy Healing) Treatment on the test formulation and cell medium (DMEM) for various skin health parameters using HFF-1, HaCaT, and B16-F10 cells. The test formulation was consisted of seven ingredients viz. zinc chloride, ferrous sulfate, copper chloride, magnesium gluconate, pyridoxine HCl, vitamin B12, and vitamin D3. The test formulation and DMEM media were divided into two parts. One part received the Biofield Energy Treatment by a renowned Biofield Energy Healer, Alice Branton and defined as the Biofield Treated (BT) sample, while other was denoted as the Untreated (UT) samples. MTT assay using test formulation showed greater than 76% cell viability, suggested safe and nontoxic profile at tested concentrations. Cell proliferation data using BrdU method showed an improved cell proliferation by 127.92% and 121.20% at 50 µg/mL in the BT-DMEM + UT-Test formulation and BT-DMEM + BT-Test formulation groups, respectively compared with the untreated group. The collagen level was significantly increased by 13.08%, and 15.98% at 50 and 100 µg/mL, respectively in the UT-DMEM + BT-Test formulation group compared with the untreated group. The level of elastin was increased by 28.09% at 50 µg/mL in the UT-DMEM + BT-Test formulation group, compared with the untreated group. Hyaluronic acid level was significantly (p≤0.001) increased by 86.10% and 35.14% at 10 and 50 µg/mL, respectively in the BT-DMEM + BT-Test formulation group as compared with the untreated group. Moreover, melanin synthesis was significantly inhibited by 16.96% at 10 µg/mL in the UT-DMEM + BT-Test formulation group compared with the untreated group. Anti-wrinkling effect exhibited improved cell viability by 65.63% and 69.95% at 1 and 10 µg/mL, respectively in the BT-DMEM + BT-Test formulation group compared with the untreated group. In vitro wound healing activity using scratch assay significantly improved healing rate and cell migration upto 58.55% in the HFF-1 cells in the UT-DMEM + BT-Test formulation group, while upto 231.25% in HaCaT cells lines in UT-DMEM + BT-Test formulation group compared with the untreated group. In conclusion, The Trivedi Effect® based test formulation and DMEM have the significant capacity to improve overall skin health, reversal of aging process and suggests its use in psoriasis, seborrheic dermatitis, skin cancer, rashes from bacterial or fungal infections, and many more skin diseases.
Article
Full-text available
Klebsiella oxytoca (K. oxytoca) is a Gram-negative microbe generally associated with community and hospital-acquired infections. Due to its clinical significance, we evaluated the effect of biofield treatment on phenotype and biotype characteristics of K. oxytoca (ATCC 43165). The study was performed into three groups i.e. C (control), T1 (treatment, revived); and T2 (treatment, lyophilized). Subsequently, groups T1 and T2 were received biofield treatment and control group was remained as untreated. The antimicrobial sensitivity results showed 3.33% and 6.67% alteration in antimicrobials susceptibility in group T1 cells on day 5 and 10, respectively, and 3.33% alteration in antimicrobials susceptibility was observed in group T2 cells on day 10 as compared to control. The sensitivity patterns of cefazolin were changed from resistant (R) to intermediate (I) on day 5, and resistance (R) to susceptible (S) on day 10, in T1 cells of K. oxytoca. The MIC value of cefazolin was decreased by 2-fold in group T1 on day 10 as compared to control. The biofield treated K. oxytoca exhibited the changes in biochemical reactions about 3.03% and 15.15% of total tested biochemicals in group T1 cells on day 5 and 10, respectively as compared to control. The biotype number of K. oxytoca was altered in biofield treated group and organism identified as Raoultella ornithinolytica in T1 on day 10 as compared to control, which is the prominent finding of this study. These changes were found in treated bacteria that might be due to some alteration happened in metabolic/enzymatic pathway and/or at genetic level of K. oxytoca. Based on these data, it is speculated that biofiled treatment could be an alternative approach that can improve the effectiveness of the existing antimicrobials against the resistant pathogens.
Article
Full-text available
Transition metal oxides (TMOs) have been known for their extraordinary electrical and magnetic properties. In the present study, some transition metal oxides (Zinc oxide, iron oxide and copper oxide) which are widely used in the fabrication of electronic devices were selected and subjected to biofield treatment. The atomic and crystal structures of TMOs were carefully studied by Fourier transform infrared (FT-IR) spectroscopy and X-ray diffraction (XRD) studies. XRD analysis reveals that biofield treatment significantly changed the lattice strain in unit cells, crystallite sizes and densities in ceramics oxide powders. The computed molecular weight of the treated samples exhibited significant variation. FT-IR spectra indicated that biofield treatment has altered the metal-oxygen bond strength. Since biofield treatment significantly altered the crystallite size, lattice strain and bond strength, we postulate that electrical and magnetic properties in TMOs (transition metal oxides) can be modulated by biofield treatment.
Article
Full-text available
Burkholderia cepacia (B. cepacia) is an opportunistic, Gram negative pathogen which causes infection mainly in immunocompromised population and associated with high rate of morbidity and mortality in cystic fibrosis patients. Aim of the present study was to analyze the impact of biofield treatment on multidrug resistant B. cepacia. Clinical sample of B. cepacia was divided into two groups i.e. control and biofield treated. The analysis was done after 10 days of treatment and compared with control group. Control and treated group were analyzed for susceptibility pattern, MIC value, biochemical studies and biotype number using MicroScan Walk-Away® system. Sensitivity assay results showed a change in pattern from resistant to intermediate in aztreonam, intermediate to resistant in ceftazidime, ciprofloxacin, imipenem, and levofloxacin while sensitive to resistant in meropenem and piperacillin/tazobactam. The biofield treatment showed an alteration in MIC values of aztreonam, ceftazidime, chloramphenicol, ciprofloxacin, imipenem, levofloxacin, meropenem, piperacillin/tazobactam and tetracycline. Biochemical reactions of treated group showed negative reaction in colistin, lysine, and ornithine while positive reactions to acetamide, arginine, and malonate as compared to control. Overall results showed an alteration of 38.9% in susceptibility pattern, 30% in MIC values of tested antimicrobials and 18.2% change in biochemical reaction after biofield treatment. A significant change in biotype number (02063736) was reported with green pigment as special characteristics after biofield treatment as compared to control (05041776) group with yellow pigment. In treated group, a new species was identified as Pseudomonas aeruginosa, as compared to control. Study findings suggest that biofield treatment has a significant effect on the phenotypic character and biotype number of multidrug resistant strain of B. Cepacia.
Article
Full-text available
Global emergence of Pseudomonas fluorescens (P. fluorescens) displays a mechanism of resistance to all existing antimicrobials. Due to its strong ability to acquire resistance, there is a need of some alternative treatment strategy. Objective of this study was to investigate the effect of biofield treatment on antimicrobial sensitivity pattern of P. fluorescens. P. fluorescens cells were procured from MicroBioLogics in sealed packs bearing the American Type Culture Collection (ATCC 49838) number. Two sets of ATCC samples were taken in this experiment and denoted as A and B. ATCC-A sample was revived and divided into two groups (Gr) i.e. Gr.I (control) and Gr.II (revived); likewise, ATCC-B was labeled as Gr.III (lyophilized). Gr.II and III were given biofield treatment and were measured by MicroScan Walk-Away® system before and after treatment. Parameters studied in experiment were antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical reactions, and biotype number of both control and treatment groups using MicroScan Walk-Away® system. Experimental results showed antimicrobials such as cefepime, cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, piperacillin, tetracycline, and tobramycin showed altered sensitivity and MIC values in treated group as compared to control. Biochemical reactions showed positive reaction in malonate, melibiose, nitrate, galactosidase, ornithine, raffinose, sorbitol, sucrose, tobramycin and Voges-Proskauer in Gr.II. Arabinose, colistin, glucose, and rhaminose also showed positive reactions in Gr.II on day 10 while arginine and cetrimide showed negative reaction in Gr.III as compared to control. Biochemical tests results revealed a change in biotype number in Gr.II (34101173, day 5), (77103177, a very rare biotype on day 10) and Gr.III (40000043) as compared to control (02041722). Organism was identified as Enterobacter cloacae (GrII, day 10) and Vibrio fluvialis (Gr.III, day 10) with respect to control. These findings suggest that biofield treatment made significant alteration in sensitivity pattern, MIC values, and biotype number of P. Fluorescens.
Article
Full-text available
Pogostemon cablin is a known aromatic plant which is cultivated for its essential oil widely applicated in perfumery and cosmetic industries. In the present study, the effect of biofield treatment was studied on the growth of P. cablin. For this study an in vitro culture system was set up in two groups, viz., control and treatment, each of which was derived from three different explant sources, namely leaf, node and petiole. Further these in vitro plantlets were hardened and transferred to external environment. The stomatal cells and epidermal hair growth were also studied at various morphogenetic stages. The study revealed that a single spell of biofield energy treatment produced significant increase in growth in treated group throughout all the morphogenetic phases from in vitro to in vivo level. A remarkable increase in stomatal cells and epidermal hair was also seen in treated group.
Article
Full-text available
This study tested the Null Hypothesis for the effect of BioField Energy applied to two separate crops under typical growing conditions, namely ginseng and organic blueberry in commercial plantings in Wisconsin and California, respectively. Following treatment to replicated plots in standard experimental design, data were collected at harvest for yield quantity and quality. Ginseng plants treated both pre-harvest and a combination of pre- and post-harvest showed market grade increases of 33.3% and 40.0%, respectively. Point of sale gross return for this crop is dependent upon tuber quality, and from these data the economics of these treatments were calculated. Based on stand adjusted yields and quality values, a combination of pre- and post-harvest treatment increased gross income by 57.4%. The second crop showed similar trends in positive responses. In the two blueberry varieties studied, Emerald treated plants showed 96% statistical increase in yield, while Jewel showed 31% increase. At the time of treatment, each variety was in a different stage of flowering. The Emerald variety was in the flowering stage, and Jewel was predominately in the fruiting stage. Both treated cultivars however demons-trated increased yield quantity and quality. The specific mechanisms that lead to these pre-liminary results need further investigation.
Article
Full-text available
Soybean production in Iowa USA is among the most productive for rainfed regions in the world. Despite generally having excellent soils, growing season temperatures and rainfall, soybean yields are decreased by weed interference and inadequate available soil water at key stages of crop development. A field study was conducted at two locations in Iowa in 2012 to determine if seed-applied fungicide or biofield treatments influenced weed community, soil volumetric water concentration and soybean yield and quality. Application of biofield treatment resulted in lower density of tall waterhemp density, greater soybean stand density at R8 stage and greater seed pod–1 compared to the absence of seed fungicide and biofield. Soil volumetric water content varied by seed fungicide x biofield x date interaction but differences were not consistent among treatment combinations. Overall, seed fungicide and biofield treatments had similar effects on soybean productivity, however additional research is necessary to determine if biofield treatment is a suitable replacement for seed fungicide application.
Article
Transition metal oxides (TMOs) have been known for their extraordinary electrical and magnetic properties. In the present study, some transition metal oxides (Zinc oxide, iron oxide and copper oxide) which are widely used in the fabrication of electronic devices were selected and subjected to biofield treatment. The atomic and crystal structures of TMOs were carefully studied by Fourier transform infrared (FT-IR) spectroscopy and X-ray diffraction (XRD) studies. XRD analysis reveals that biofield treatment significantly changed the lattice strain in unit cells, crystallite sizes and densities in ceramics oxide powders. The computed molecular weight of the treated samples exhibited significant variation. FT-IR spectra indicated that biofield treatment has altered the metal-oxygen bond strength. Since biofield treatment significantly altered the crystallite size, lattice strain and bond strength, we postulate that electrical and magnetic properties in TMOs (transition metal oxides) can be modulated by biofield treatment.
Article
Quantum mechanics was developed when human energies of consciousness were found to influence observations at the scale of elementary particles, here referred as non-contact biofield treatment or biofield energies. Quantum mechanics has also proved ef-ficacious in biological processes. The present experiments found an enhanced and significant impact of the biofield treatment on adaptive micropropagation response and callus induction of two plant species , Withania somnifera and Amaranthus dubius. The enhancement was perhaps due to greater focus on adaptation rather than specific mechanisms, showing high potential including at biochemical and genetic levels. Possible reasons for the enhancement are discussed and a possible model is presented, consistent with current scientific theory.